Search people, articles, bills, and more
Currently, people with severe food allergies or celiac disease face a challenge when taking medications because drug labels are not consistently required to disclose common allergens or gluten. This lack of information can put them at risk of accidental exposure, leading to serious allergic reactions or health complications. This bill addresses a significant gap in consumer safety information, providing a vital tool for patients to protect themselves.
If this bill becomes law, it will empower individuals with allergies and celiac disease to confidently select medications, reducing anxiety and the risk of adverse health events. If it doesn't pass, the current situation of inconsistent or absent allergen and gluten labeling on drugs will persist, leaving these vulnerable populations to navigate potential risks without readily available information.
No reactions yet. Be the first to weigh in.
Currently, people with severe food allergies or celiac disease face a challenge when taking medications because drug labels are not consistently required to disclose common allergens or gluten. This lack of information can put them at risk of accidental exposure, leading to serious allergic reactions or health complications. This bill addresses a significant gap in consumer safety information, providing a vital tool for patients to protect themselves.
If this bill becomes law, it will empower individuals with allergies and celiac disease to confidently select medications, reducing anxiety and the risk of adverse health events. If it doesn't pass, the current situation of inconsistent or absent allergen and gluten labeling on drugs will persist, leaving these vulnerable populations to navigate potential risks without readily available information.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| TYPE | AMOUNT | WHO |
|---|---|---|
| Administrative/Civil/Criminal | Not specified in this bill; however, being 'misbranded' under the Federal Food, Drug, and Cosmetic Act carries various penalties, including seizure of products, injunctions, and potentially fines or imprisonment for responsible individuals. | Drug manufacturers and distributors of misbranded drugs |